0
Pharmacy Benefits Manager Accountability Act
1/4/2025, 11:12 AM
Summary of Bill HR 2679
The bill requires PBMs to disclose certain information, such as the amount of rebates they receive from drug manufacturers and the discounts they negotiate with pharmacies. This information must be reported to the Department of Health and Human Services (HHS) on a regular basis.
Additionally, the bill prohibits PBMs from engaging in certain anti-competitive practices, such as steering patients to certain pharmacies or drug manufacturers in exchange for kickbacks. It also requires PBMs to pass on any rebates or discounts they receive to the health insurance plans they work with, in order to lower prescription drug costs for consumers. Overall, the Pharmacy Benefits Manager Accountability Act seeks to increase transparency and competition in the pharmaceutical industry, ultimately leading to lower prescription drug costs for Americans.
Congressional Summary of HR 2679
Pharmacy Benefits Manager Accountability Act
This bill establishes reporting requirements for pharmacy benefit managers (PBMs) with respect to services provided to health insurance plans.
First, PBMs must report annually to the plan sponsor certain information about the PBM's services, including the amount of prescription drug copayment assistance funded by drug manufacturers, a list of covered drugs billed under the plan during the reporting period, and the total gross and net spending by the health plan on prescription drugs during the reporting period. PBMs also must submit specified elements of the report (e.g., the total gross spending on prescription drugs) to the Government Accountability Office (GAO). The report must comply with the privacy requirements under the Health Insurance Portability and Accountability Act of 1996.
The bill establishes civil penalties for violations of these requirements and provides for enforcement by the appropriate agencies.
GAO must report on the pharmacy networks of plans or PBMs, including whether such networks under common ownership with the plans or PBMs are designed to encourage plan enrollees to use network pharmacies over other pharmacies.
Read the Full Bill
Current Status of Bill HR 2679
Bipartisan Support of Bill HR 2679
Total Number of Sponsors
3Democrat Sponsors
3Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
8Democrat Cosponsors
4Republican Cosponsors
4Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 2679
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 2679
Comments

Saint Brandt
11 months ago
I don't like this new bill about pharmacy stuff, it's gonna mess with my meds and cost me more money. Can't believe they're trying to push this through without thinking about us regular folks.





